The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, we will present results from two studies from the UK and France. The COPING study assesses the impact of the novel coronavirus (COVID-19) pandemic on mental and neurological health, and how different factors associated with the virus are affecting the population. The CoCo-Neuro study characterises the neurological and psychiatric manifestations occurring in the context of Covid-19 infection and aims to improve clinical management, rehabilitation and follow-up.
Chair: Prof Tom Solomon, Liverpool Brain Infections Group
Dr Cécile Delorme, Pitié-Salpêtrière Hospital, France: Neuropsychiatric manifestations in patients with Covid-19 : the Pitié-Salpêtrière experience
Professor Gerome Breen, King's College London, United Kingdom: TBC
Brain Infections Global: An NIHR Global Health Research Group on Improving the Management of Acute Brain Infections